ArticleFrontiers in oncology2024

Case report: Increased efficacy of cetuximab after pembrolizumab failure in cutaneous squamous cell carcinoma.

Renee Morecroft et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.